Aspect Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
AIM
AAMU
AAIS
BCAM
JWM
Aspect Partners's DGX Position: Q2 2026 in Review
Aspect Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 14 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #483.
Aspect Partners first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Aspect Partners held 14 shares of Quest Diagnostics worth $2.97K as of Q2 2026.
- Aspect Partners left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #483 holding.
- Aspect Partners first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
- 254 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.